Chairman of the Supervisory Board
medicine
HTL-STREFA
Poland
Gerardus van Odijk has over 25 years of experience in the European healthcare industry. Up until 2012, Mr van Odijk was the CEO of Teva Pharmaceuticals Europe – a global leader in pharmaceuticals with revenue of approximately $20bn and over 42,000 employees. Mr. van Odijk has also held various senior management positions with GSK Plc, most recently holding the position of SVP and Area Director Northern Europe.Mr. van Odijk is currently the Chairman of Bavarian Nordic and a Non-Executive Director of UDG. Gerard has degree of Medical Doctor from the University of Utrecht.
Gerard Van Odijk has broad interests in the Medicine and research thus far has focused on health care industries.